Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Allergy diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product & service trends
2.1.4 Test type trends
2.1.5 Allergen trends
2.1.6 End-use trends
Chapter 3 Allergy Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence and high economic burden of allergic diseases
3.2.1.2 Growing pollution levels coupled with rise in respiratory disorders
3.2.1.3 Technological advancements in new products
3.2.1.4 Rise in funding for allergy diagnostics companies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of allergy diagnostic instruments
3.2.2.2 Limited awareness related to allergic diseases
3.3 Growth potential analysis
3.3.1 By product & service
3.3.2 By test type
3.3.3 By allergen
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Evolution of diagnostic allergen testing
3.9 Future market trends
3.10 Epidemiology scenario
3.11 Patent landscape
3.12 Porter’s analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Company market share analysis
4.6 Strategy dashboard, 2022
Chapter 5 Allergy Diagnostics Market Size and Forecast, By Product & Service (USD Million)
5.1 Key product & service trends
5.2 Consumables
5.3 Instruments
5.4 Services
Chapter 6 Allergy Diagnostics Market Size and Forecast, By Test Type (USD Million)
6.1 Key test type trends
6.2 In vivo
6.2.1 Skin Prick Tests
6.2.2 Intradermal Skin Test
6.2.3 Others
6.3 In vitro
Chapter 7 Allergy Diagnostics Market Size and Forecast, By Allergen (USD Million)
7.1 Key allergen trends
7.2 Inhaled Allergens
7.3 Food Allergens
7.4 Drug Allergens
7.5 Other Allergens
Chapter 8 Allergy Diagnostics Market Size and Forecast, By End-use (USD Million)
8.1 Key end-use trends
8.2 Hospital-based Laboratories
8.3 Diagnostic Laboratories
8.4 Others
Chapter 9 Allergy Diagnostics Market Size and Forecast, By Region (USD Million)
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Vietnam
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Turkey
9.6.5 Israel
9.6.6 Iran
Chapter 10 Company Profiles
10.1 Danaher Corporation
10.2 Thermo Fisher Scientific Inc.
10.3 Omega Diagnostics Group PLC
10.4 Siemens Healthcare Diagnostics, Inc.
10.5 Stallergenes SA
10.6 Hitachi Chemical Diagnostic Inc.
10.7 Lincoln Diagnostics, Inc.
10.8 Eurofins Scientific
10.9 Minaris Medical America, Inc.
10.10 EUROIMMUN Medizinische Labordiagnostika AG
10.11 bioMérieux SA
10.12 HOB Biotech Group Corp., Ltd.
10.13 R-Biopharm AG
10.14 HYCOR Biomedical
10.15 Neogen Corporation
